Recurrent epimutation ofSDHCin gastrointestinal stromal tumors
- 24 December 2014
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 6 (268) , 268ra177
Abstract
Methylation of theSDHgene explains the loss ofSDHgene expression in SDH wild-type gastrointestinal stromal tumors.Keywords
This publication has 30 references indexed in Scilit:
- The role of mutation of metabolism-related genes in genomic hypermethylationBiochemical and Biophysical Research Communications, 2014
- SDH Mutations Establish a Hypermethylator Phenotype in ParagangliomaCancer Cell, 2013
- Succinate Dehydrogenase Mutation Underlies Global Epigenomic Divergence in Gastrointestinal Stromal TumorCancer Discovery, 2013
- Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumorsFrontiers in Oncology, 2013
- Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressorsGenes & Development, 2012
- Succinate dehydrogenase (SDH) and mitochondrial driven neoplasiaPathology, 2012
- Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cellsMolecular Cancer, 2009
- Cell-Permeating α-Ketoglutarate Derivatives Alleviate Pseudohypoxia in Succinate Dehydrogenase-Deficient CellsMolecular and Cellular Biology, 2007
- Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutationsHuman Molecular Genetics, 2005
- Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylaseCancer Cell, 2005